United States Respiratory Distress Syndrome Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Respiratory Distress Syndrome Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Respiratory Distress Syndrome Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Respiratory Distress Syndrome Overall Market Size
2.1 United States Respiratory Distress Syndrome Market Size: 2021 VS 2027
2.2 United States Respiratory Distress Syndrome Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Distress Syndrome Players in United States Market
3.2 Top United States Respiratory Distress Syndrome Companies Ranked by Revenue
3.3 United States Respiratory Distress Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Distress Syndrome Companies in United States Market, by Revenue in 2020
3.5 Companies Respiratory Distress Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Distress Syndrome Players in United States Market
3.6.1 List of Tier 1 Respiratory Distress Syndrome Companies in United States
3.6.2 List of Tier 2 and Tier 3 Respiratory Distress Syndrome Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Respiratory Distress Syndrome Market Size Markets, 2021 & 2027
4.1.2 Poractant Alfa
4.1.3 Beractant
4.1.4 Calfactant
4.1.5 Others
4.2 By Type - United States Respiratory Distress Syndrome Revenue & Forecasts
4.2.1 By Type - United States Respiratory Distress Syndrome Revenue, 2016-2021
4.2.2 By Type - United States Respiratory Distress Syndrome Revenue, 2022-2027
4.2.3 By Type - United States Respiratory Distress Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Respiratory Distress Syndrome Market Size, 2021 & 2027
5.1.2 Very Preterm Infants
5.1.3 Moderate to Late Preterm Infants
5.1.4 Others
5.2 By Application - United States Respiratory Distress Syndrome Revenue & Forecasts
5.2.1 By Application - United States Respiratory Distress Syndrome Revenue, 2016-2021
5.2.2 By Application - United States Respiratory Distress Syndrome Revenue, 2022-2027
5.2.3 By Application - United States Respiratory Distress Syndrome Revenue Market Share, 2016-2027
6 Respiratory Distress Syndrome Companies Profiles
6.1 Chiesi Farmaceutici
6.1.1 Chiesi Farmaceutici Company Details
6.1.2 Chiesi Farmaceutici Business Overview
6.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction
6.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.1.5 Chiesi Farmaceutici Recent Developments
6.2 CR-Double Crane
6.2.1 CR-Double Crane Company Details
6.2.2 CR-Double Crane Business Overview
6.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction
6.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.2.5 CR-Double Crane Recent Developments
6.3 ONY Biotech
6.3.1 ONY Biotech Company Details
6.3.2 ONY Biotech Business Overview
6.3.3 ONY Biotech Respiratory Distress Syndrome Introduction
6.3.4 ONY Biotech Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.3.5 ONY Biotech Recent Developments
6.4 AbbVie
6.4.1 AbbVie Company Details
6.4.2 AbbVie Business Overview
6.4.3 AbbVie Respiratory Distress Syndrome Introduction
6.4.4 AbbVie Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.4.5 AbbVie Recent Developments
6.5 Yuhan Corporation
6.5.1 Yuhan Corporation Company Details
6.5.2 Yuhan Corporation Business Overview
6.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction
6.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.5.5 Yuhan Corporation Recent Developments
6.6 JW Pharmaceuticals
6.6.1 JW Pharmaceuticals Company Details
6.6.2 JW Pharmaceuticals Business Overview
6.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction
6.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.6.5 JW Pharmaceuticals Recent Developments
6.7 Noargen
6.7.1 Noargen Company Details
6.7.2 Noargen Business Overview
6.7.3 Noargen Respiratory Distress Syndrome Introduction
6.7.4 Noargen Respiratory Distress Syndrome Revenue in United States Market (2016-2021)
6.7.5 Noargen Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Respiratory Distress Syndrome Market Opportunities & Trends in United States Market
Table 2. Respiratory Distress Syndrome Market Drivers in United States Market
Table 3. Respiratory Distress Syndrome Market Restraints in United States Market
Table 4. Key Players of Respiratory Distress Syndrome in United States Market
Table 5. Top Respiratory Distress Syndrome Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Respiratory Distress Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Respiratory Distress Syndrome Revenue Share by Companies, 2016-2021
Table 8. Companies Respiratory Distress Syndrome Product Type
Table 9. List of Tier 1 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Respiratory Distress Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Respiratory Distress Syndrome Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Respiratory Distress Syndrome Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Respiratory Distress Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Respiratory Distress Syndrome Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Respiratory Distress Syndrome Revenue (US$, Mn), 2022-2027
Table 17. Chiesi Farmaceutici Company Details
Table 18. Chiesi Farmaceutici Business Overview
Table 19. Chiesi Farmaceutici Respiratory Distress Syndrome Product
Table 20. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Chiesi Farmaceutici Recent Developments
Table 22. CR-Double Crane Company Details
Table 23. CR-Double Crane Business Overview
Table 24. CR-Double Crane Respiratory Distress Syndrome Product
Table 25. CR-Double Crane Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. CR-Double Crane Recent Developments
Table 27. ONY Biotech Company Details
Table 28. ONY Biotech Business Overview
Table 29. ONY Biotech Respiratory Distress Syndrome Product
Table 30. ONY Biotech Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. ONY Biotech Recent Developments
Table 32. AbbVie Company Details
Table 33. AbbVie Business Overview
Table 34. AbbVie Respiratory Distress Syndrome Product
Table 35. AbbVie Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. AbbVie Recent Developments
Table 37. Yuhan Corporation Company Details
Table 38. Yuhan Corporation Business Overview
Table 39. Yuhan Corporation Respiratory Distress Syndrome Product
Table 40. Yuhan Corporation Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Yuhan Corporation Recent Developments
Table 42. JW Pharmaceuticals Company Details
Table 43. JW Pharmaceuticals Business Overview
Table 44. JW Pharmaceuticals Respiratory Distress Syndrome Product
Table 45. JW Pharmaceuticals Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. JW Pharmaceuticals Recent Developments
Table 47. Noargen Company Details
Table 48. Noargen Business Overview
Table 49. Noargen Respiratory Distress Syndrome Product
Table 50. Noargen Respiratory Distress Syndrome Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Noargen Recent Developments
List of FiguresFigure 1. Respiratory Distress Syndrome Segment by Type
Figure 2. Respiratory Distress Syndrome Segment by Application
Figure 3. United States Respiratory Distress Syndrome Market Overview: 2020
Figure 4. United States Respiratory Distress Syndrome Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Respiratory Distress Syndrome Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2020
Figure 7. By Type - United States Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 8. By Application - United States Respiratory Distress Syndrome Revenue Market Share, 2016-2027
Figure 9. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CR-Double Crane Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. ONY Biotech Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. AbbVie Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Yuhan Corporation Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. JW Pharmaceuticals Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Noargen Respiratory Distress Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)